Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
14,318.00    256.00 (1.82%)
Bid:
14,256.00
Ask:
14,262.00
Spread: 6.00 (0.042%)
Market Cap: £222.05b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

LONDON MARKET CLOSE: FTSE 100 rises despite tariff worries; M&G shines
30 May 2025

LONDON MARKET CLOSE: FTSE 100 rises despite tariff worries; M&G shines

(Alliance News) - The FTSE 100 outperformed in a mixed day for European equities, after the US Court of Appeals temporarily reinstated Donald Trump's ...

Danaher partners with AstraZeneca to develop AI diagnostics
30 May 2025

Danaher partners with AstraZeneca to develop AI diagnostics

(Alliance News) - Danaher Corp on Thursday said it has entered a partnership with AstraZeneca PLC to develop and commercialise tools and tests for pre...

Angle shares fall on weak 2025 outlook despite narrower annual loss
28 May 2025

Angle shares fall on weak 2025 outlook despite narrower annual loss

(Alliance News) - Angle PLC on Wednesday said its annual loss narrowed in 2024 as revenue rose and operating costs fell, though the company warned tha...

LONDON BROKER RATINGS: RBC cuts National Grid; Citigroup cuts South32
28 May 2025

LONDON BROKER RATINGS: RBC cuts National Grid; Citigroup cuts South32

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

LONDON MARKET CLOSE: Tariff optimism, US data lifts FTSE 100
27 May 2025

LONDON MARKET CLOSE: Tariff optimism, US data lifts FTSE 100

(Alliance News) - Stock prices in Europe ended largely higher on Tuesday, building on a confident start to the week, while equities in London also got...

AstraZeneca bladder cancer drug Imfinzi recommended for EU approval
27 May 2025

AstraZeneca bladder cancer drug Imfinzi recommended for EU approval

(Alliance News) - AstraZeneca PLC on Tuesday said its Imfinzi, or durvalumab, therapy has been recommended for approval in the EU for the treatment of...

EU recommends AstraZeneca bladder cancer treatment for approval
27 May 2025

EU recommends AstraZeneca bladder cancer treatment for approval

(Sharecast News) - EU regulators have recommended AstraZeneca's Imfinzi for approval in the treatment muscle-invasive bladder cancer (MIBC).

LONDON BRIEFING: Bodycote revenue falls; Inspired mulls possible offer
27 May 2025

LONDON BRIEFING: Bodycote revenue falls; Inspired mulls possible offer

(Alliance News) - London's FTSE 100 is called higher on Tuesday following a bank holiday-lengthened weekend, as Nato members are expected to raise def...